ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260060.1	Methotrexate	Breast invasive carcinoma	0.019752392	Resistant
ENSG00000260060.1	Methotrexate	Liver hepatocellular carcinoma	0.038777357	Resistant